Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 10 869-873, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Association between coronary heart disease and cancers of the breast, prostate, and colon

AI Neugut, DJ Rosenberg, H Ahsan, JS Jacobson, N Wahid, M Hagan, MI Rahman, ZR Khan, L Chen, A Pablos-Mendez and S Shea
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

Coronary heart disease (CHD) and cancers of the breast, prostate, and colon are more common in industrialized countries than in the developing world, and to some degree, these conditions appear to share risk factors. To investigate whether there is an association between these cancers and a prior history of CHD, a hospital-based case-control study was conducted at Columbia-Presbyterian Medical Center in New York. The study was based on 252 breast cancer cases, 256 colorectal cancer cases, and 322 benign surgical controls, all of whom underwent biopsy or surgery between January 1989 and December 1992, and on 319 prostate cancer cases and 189 benign prostatic hypertrophy controls diagnosed between January 1984 and December 1986 (prior to widespread use of prostate-specific antigen screening). Medical records were reviewed on each, focusing on the preoperative anesthesia and surgical clearances. No association was found between a history of CHD and breast or colorectal cancer, but an elevated risk was found for prostate cancer (odds ratio, 2.00; 95% confidence interval, 1.18-3.39), using unconditional logistic regression with adjustment for appropriate confounders. No association was found between cigarette smoking and any of the three cancers. Aspirin use was protective for colorectal cancer (odds ratio, 0.35; 95% confidence interval, 0.17-0.73) but had no association with breast or prostate cancer. The study suggests that individuals with CHD are at elevated risk for prostate cancer but not breast or colorectal cancer. Etiological risk factors associated with CHD should be investigated with regard to prostate cancer. Patients with CHD may represent a high-risk group for prostate cancer and potential future targets for prostate cancer screening interventions.

This article has been cited by other articles:

				B. Takkouche, C. Regueira-Mendez, and M. Etminan Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis J Natl Cancer Inst, October 15, 2008; 100(20): 1439 - 1447. [Abstract] [Full Text] [PDF]

				A. G. Hudson, G. L. Gierach, F. Modugno, J. Simpson, J. W. Wilson, R. W. Evans, V. G. Vogel, and J. L. Weissfeld Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 680 - 687. [Abstract] [Full Text] [PDF]

				N. Ishizaka, Y. Ishizaka, E.-I. Toda, K. Koike, M. Yamakado, and R. Nagai Are Serum Carcinoembryonic Antigen Levels Associated With Carotid Atherosclerosis in Japanese Men? Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 160 - 165. [Abstract] [Full Text] [PDF]

				A. O. O. Chan, M. H. Jim, K. F. Lam, J. S. Morris, D. C. W. Siu, T. Tong, F. H. Ng, S. Y. Wong, W. M. Hui, C. K. Chan, et al. Prevalence of Colorectal Neoplasm Among Patients With Newly Diagnosed Coronary Artery Disease JAMA, September 26, 2007; 298(12): 1412 - 1419. [Abstract] [Full Text] [PDF]

				M. Allison, C. Garland, R. Chlebowski, M. Criqui, R. Langer, L. Wu, H. Roy, A. McTiernan, L. Kuller, and for the Women's Health Initiative Investigators The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women Am. J. Epidemiol., September 15, 2006; 164(6): 567 - 575. [Abstract] [Full Text] [PDF]

				Y. Zhang, P. F. Coogan, J. R. Palmer, B. L. Strom, and L. Rosenberg Use of Nonsteroidal Antiinflammatory Drugs and Risk of Breast Cancer: The Case-Control Surveillance Study Revisited Am. J. Epidemiol., July 15, 2005; 162(2): 165 - 170. [Abstract] [Full Text] [PDF]

				E. J. Jacobs, C. Rodriguez, A. M. Mondul, C. J. Connell, S. J. Henley, E. E. Calle, and M. J. Thun A Large Cohort Study of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer Incidence J Natl Cancer Inst, July 6, 2005; 97(13): 975 - 980. [Abstract] [Full Text] [PDF]

				S. F. Marshall, L. Bernstein, H. Anton-Culver, D. Deapen, P. L. Horn-Ross, H. Mohrenweiser, D. Peel, R. Pinder, D. M. Purdie, P. Reynolds, et al. Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status J Natl Cancer Inst, June 1, 2005; 97(11): 805 - 812. [Abstract] [Full Text] [PDF]

				E. J. Jacobs, M. J. Thun, C. J. Connell, C. Rodriguez, S. J. Henley, H. S. Feigelson, A. V. Patel, W. D. Flanders, and E. E. Calle Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Breast Cancer Incidence in a Large U.S. Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 261 - 264. [Abstract] [Full Text] [PDF]

				L. A. Garcia Rodriguez and A. Gonzalez-Perez Inverse Association between Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 649 - 653. [Abstract] [Full Text] [PDF]

				J. M Herendeen and C. Lindley Use of NSAIDs for the Chemoprevention of Colorectal Cancer Ann. Pharmacother., November 1, 2003; 37(11): 1664 - 1674. [Abstract] [Full Text] [PDF]

				P. M. Brauer, G. E. McKeown-Eyssen, V. Jazmaji, A. G. Logan, D. F. Andrews, D. Jenkins, N. Marcon, F. Saibil, L. Cohen, H. Stern, et al. Familial Aggregation of Diabetes and Hypertension in a Case-Control Study of Colorectal Neoplasia Am. J. Epidemiol., October 15, 2002; 156(8): 702 - 713. [Abstract] [Full Text] [PDF]

				M. F. Leitzmann, M. J. Stampfer, J. Ma, J. M. Chan, G. A. Colditz, W. C. Willett, and E. Giovannucci Aspirin Use in Relation to Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1108 - 1111. [Abstract] [Full Text] [PDF]

				I. F. Orengo, J. Gerguis, R. Phillips, A. Guevara, A. T. Lewis, and H. S. Black Celecoxib, a Cyclooxygenase 2 Inhibitor as a Potential Chemopreventive to UV-Induced Skin Cancer: A Study in the Hairless Mouse Model Arch Dermatol, June 1, 2002; 138(6): 751 - 755. [Abstract] [Full Text] [PDF]

				V. L. Ernster, J. Barclay, K. Kerlikowske, H. Wilkie, and R. Ballard-Barbash Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program Arch Intern Med, April 10, 2000; 160(7): 953 - 958. [Abstract] [Full Text] [PDF]

				L. Dreyer and J. H. Olsen Risk for Non-smoking-related Cancer in Atherosclerotic Patients Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 915 - 918. [Abstract] [Full Text]

				M. A. Smith, B. Freidlin, L. A. G. Ries, and R. Simon RESPONSE: Re: Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States J Natl Cancer Inst, June 2, 1999; 91(11): 973b - 974b. [Full Text] [PDF]